Are Topical Steroids a Risk Factor for Tube Exposure in Glaucoma Drainage Devices?
Alex M Ragan, 1 Gavin Docherty, 2 Andrew Crichton 1 1Division of Ophthalmology, Department of Surgery, University of Calgary, Calgary, Alberta, Canada; 2Division of Ophthalmology, Department of Surgery, Kelowna, British Columbia, CanadaCorrespondence: Andrew Crichton Email andrew.crichton@albertah...
Guardado en:
Autores principales: | Ragan AM, Docherty G, Crichton A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7bcb58b81a90416fbf1661cd925293c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tube Revision Outcomes for Exposure with Different Repair Techniques
por: Alawi A, et al.
Publicado: (2020) -
Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery
por: Chaku M, et al.
Publicado: (2016) -
Comparison of Two Tube-Modification Techniques in Baerveldt Glaucoma Implantation in Refractory Glaucoma
por: Petpiroon P, et al.
Publicado: (2020) -
Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
por: Noor NA, et al.
Publicado: (2017) -
The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy
por: Poelman HJ, et al.
Publicado: (2020)